To show that PKCε-induced NEP activity degrades Aβ, human neuroblastoma cells were treated with bryostatin with or without PKCε inhibitor or NEP inhibitor and then exposed to monomeric Aβ 1–42 peptides. Here, PRKCE is linked to neuroblastoma.